ABBOTT LABORATORIES — Director's Dealing 2008

Feb 13, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-02-08

Reporting Person: Chen Thomas F (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-02-08	Common shares without par value	M	15202	$49.4617	Acquired	85272	Direct
2008-02-08	Common shares without par value	M	20727	$44.96	Acquired	105999	Direct
2008-02-08	Common shares without par value	S	400	$56.7100	Disposed	105599	Direct
2008-02-08	Common shares without par value	S	100	$56.7200	Disposed	105499	Direct
2008-02-08	Common shares without par value	S	4100	$56.7300	Disposed	101399	Direct
2008-02-08	Common shares without par value	S	3700	$56.7400	Disposed	97699	Direct
2008-02-08	Common shares without par value	S	10900	$56.7500	Disposed	86799	Direct
2008-02-08	Common shares without par value	S	4700	$56.7600	Disposed	82099	Direct
2008-02-08	Common shares without par value	S	4800	$56.7700	Disposed	77299	Direct
2008-02-08	Common shares without par value	S	6729	$56.7800	Disposed	70570	Direct
2008-02-08	Common shares without par value	S	400	$56.7900	Disposed	70170	Direct
2008-02-08	Common shares without par value	S	100	$56.8000	Disposed	70070	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-02-08	Option (right to buy)	$49.4617	M	15202	Disposed	2008-12-12	common shares (15202)	Direct
2008-02-08	Option (right to buy)	$44.96	M	20727	Disposed	2008-12-12	common shares (20727)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	17432	Indirect
Common shares without par value	23798	Indirect
Common shares without par value	2476	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 8, 2008

F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughter.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.